Quality and Safety

To highlight their HIMSS23 session, Margie Zuk and Penny Chase of MITRE share updates to the Medical Device Cybersecurity Regional Incident Preparedness and Response Playbook.  

Key information in clinical decision-making tools needs to be rapidly scanned to be useful at the point of care.

The FDA has approved the first nonprescription OTC naloxone nasal spray, Narcan.

Fresenius Medical Care SVP and global chief medical information officer Dr. Shelly Nash will lead a panel at HIMSS23 on the ways the right training and technology can help end-stage kidney disease patients perform dialysis at home.

Aimee Cardwell, SVP and CISO at UnitedHealth Group, highlights her upcoming HIMSS23 presentation, focused on using your personnel and network to build resilience.  

An upcoming HIMSS23 panel will look at how machine learning can find discharge medication errors. Wendy Paul, medication process architect at Seattle Children's Hospital, and Kyle Longhurst, product manager at Pariveda, explain.

Florence Hudson, executive director of Columbia University's Northeast Big Data Innovation Hub, previews her HIMSS23 look at the new IoT specification meant to help medical devices communicate safely and securely.

Staffing issues and an ongoing nursing shortage continue to cause challenges for the nation's nursing workforce.

Tom O’Neil, managing director of Berkeley Research Group, says boards need to ask the right questions to get AI right and consider factors like efficacy and transparency.  

The transition of shared medical appointments from in-person to virtual formats can benefit patients and providers. Cleveland Clinic's Dr. Marianne Sumego, director of shared medical appointments, previews her upcoming HIMSS23 talk on the subject.